Optinose, Inc. IPO Research Information

Optinose, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Optinose, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Optinose, Inc.	OPTN - NASDAQ	$15.00-$17.00	$16.00	$20.00	7.5 million	10/13/2017
Underwriter(s): Jefferies, Piper Jaffray, BMO Capital Markets, RBC Capital Markets
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2017-09-18 Terms Added 2017-10-03

Optinose, Inc. Quote & Chart - Click for current quote - OPTN

About Optinose, Inc. (adapted from Optinose, Inc. prospectus):
They are a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "OPTN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.